Market Cap (In USD)
8070.00
Revenue (In USD)
77.04 Thousand
Net Income (In USD)
-14.14 Million
Avg. Volume
7104.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.2537
- PE
- -
- EPS
- -
- Beta Value
- 0.083
- ISIN
- US6404422080
- CUSIP
- 640442208
- CIK
- 1602078
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Dr. Dewan Fazlul Hoque Chowdhury Ph.D.
- Employee Count
- -
- Website
- https://nemauramedical.com
- Ipo Date
- 2018-02-05
- Details
- Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
More Stocks
-
SCCC-R
-
SULIPT SLJ Global Tbk
SULI
-
OSP
-
BCH-R
-
ABVL
-
ASHTFAshtead Group plc
ASHTF
-
PRESTIGEPrestige Estates Projects Limited
PRESTIGE
-
ATM